Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

BioCardia completes roll-in cohort in CardiAMP heart failure trial

July 27, 2017

BAY-386, a novel PAR1 receptor inhibitor for arterial thrombosis

July 21, 2017

NIH grant supports UIC evaluation of TAT-PTEN9c to improve survival post heart attack

July 18, 2017

Chengdu Baiyu Ginkgolide Pharmaceuticals divulges ginkgolide B derivatives

July 14, 2017

Bristol-Myers Squibb divulges apelin receptor agonists

July 12, 2017

Arena reports phase II results for ralinepag in PAH

July 11, 2017

Inotrem initiates phase II study of Motrem for septic shock

July 10, 2017

BioTech to pursue critical limb ischemia as first Procell indication based on pilot clinical data

July 10, 2017

Janssen decides not to exercise option to Capricor's CAP-1002 in cardiology

July 7, 2017

SteadyMed submits NDA for Trevyent for PAH

July 3, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Case report links APOLD1 variant to vascular-type bleeding disorder
BioWorld Science
Vascular-type bleeding disorder (BDVAS) is a rare, autosomal dominant disorder mainly caused by impaired vascular integrity.